Drugs / Tesmilifene
Tesmilifene
also known as
YMB 1002 · BMS-217380-01 · BMY-33419 · DPP-E · NSC-741196 · Tesmilifene hcl · TESMILIFENE HYDROCHLORIDE · Tesmilifeno
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00364754 | May 2004 → Jan 2006 | breast carcinoma | YM BioSciences | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00364195 | Jun 2006 → ? | breast cancer | YM BioSciences | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tesmilifene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00364754 ↗ |
| Known as | BMS-217380-01 | ChEMBL registry synonym — accepted as the source's own label CHEMBL26424 ↗ |
| Known as | BMY-33419 | ChEMBL registry synonym — accepted as the source's own label CHEMBL26424 ↗ |
| Known as | DPP-E | ChEMBL registry synonym — accepted as the source's own label CHEMBL26424 ↗ |
| Known as | NSC-741196 | ChEMBL registry synonym — accepted as the source's own label CHEMBL26424 ↗ |
| Known as | Tesmilifene hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL26424 ↗ |
| Known as | TESMILIFENE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL26424 ↗ |
| Known as | Tesmilifeno | ChEMBL registry synonym — accepted as the source's own label CHEMBL26424 ↗ |
| Known as | YMB 1002 | “Tesmilifene (YMB 1002)” NCT00364754 ↗1“Tesmilifene (YMB1002)” NCT00364195 ↗ |
| Modality | Small molecule | — CHEMBL26424 ↗ |